These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 12403076)

  • 1. Enhanced percutaneous absoption of piroxicam via salt formation with ethanolamines.
    Cheong HA; Choi HK
    Pharm Res; 2002 Sep; 19(9):1375-80. PubMed ID: 12403076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ethanolamine salts and enhancers on the percutaneous absorption of piroxicam from a pressure sensitive adhesive matrix.
    Cheong HA; Choi HK
    Eur J Pharm Sci; 2003 Feb; 18(2):149-53. PubMed ID: 12594008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of meloxicam/ethanolamine salt formation on percutaneous absorption of meloxicam.
    Ki HM; Choi HK
    Arch Pharm Res; 2007 Feb; 30(2):215-21. PubMed ID: 17366744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced bioavailability of piroxicam via salt formation with ethanolamines.
    Gwak HS; Choi JS; Choi HK
    Int J Pharm; 2005 Jun; 297(1-2):156-61. PubMed ID: 15907602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin.
    Gwak HS; Chun IK
    Int J Pharm; 2002 Apr; 236(1-2):57-64. PubMed ID: 11891070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced skin permeation of 6-methoxy-2-naphthylacetic acid by salt formation.
    Pawar V; Kumar HY; Giridhar R; Yadav MR
    Drug Deliv; 2015 May; 22(3):359-66. PubMed ID: 24670100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of non-ionic surfactants, pH and propylene glycol on percutaneous absorption of piroxicam from cataplasm.
    Okuyama H; Ikeda Y; Kasai S; Imamori K; Takayama K; Nagai T
    Int J Pharm; 1999 Sep; 186(2):141-8. PubMed ID: 10486432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing Skin Permeation of Biphenylacetic Acid (BPA) Using Salt Formation with Organic and Alkali Metal Bases.
    Pawar V; Naik P; Giridhar R; Yadav MR
    Sci Pharm; 2015; 83(1):191-205. PubMed ID: 26839810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal lontophoresis and skin retention of piroxicam from gels containing piroxicam: hydroxypropyl-beta-cyclodextrin complexes.
    Doliwa A; Santoyo S; Ygartua P
    Drug Dev Ind Pharm; 2001 Sep; 27(8):751-8. PubMed ID: 11699826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved absorption of meloxicam via salt formation with ethanolamines.
    Han HK; Choi HK
    Eur J Pharm Biopharm; 2007 Jan; 65(1):99-103. PubMed ID: 16919925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of piroxicam: hydroxypropyl-beta-cyclodextrin complexation on the in vitro permeation and skin retention of piroxicam.
    Doliwa A; Santoyo S; Ygartua P
    Skin Pharmacol Appl Skin Physiol; 2001; 14(2):97-107. PubMed ID: 11316968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo Skin Permeation Evaluation of An Innovative Transdermal Vehicle Using Nimesulide and Piroxicam as Model Drugs.
    Pereira RO; Pelisson E Silva TCC; de Oliveira Ferreira A; Brandao MAF; Raposo NRB; Polonini HC
    Curr Drug Deliv; 2017; 14(4):516-520. PubMed ID: 27557671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing effects of fatty acids on piroxicam permeation through rat skins.
    Shin SC; Shin EY; Cho CW
    Drug Dev Ind Pharm; 2000 May; 26(5):563-6. PubMed ID: 10789070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of enhancers on cutaneous permeation of piroxicam in vitro].
    Xu GQ; Xi NZ; Chen GS; Jiang XG; Xu HN
    Zhongguo Yao Li Xue Bao; 1991 May; 12(3):235-8. PubMed ID: 1781286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of complexation with alkanolamines to facilitate skin permeation of mefenamic acid.
    Fang L; Numajiri S; Kobayashi D; Morimoto Y
    Int J Pharm; 2003 Aug; 262(1-2):13-22. PubMed ID: 12927383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeation of piroxicam from the poloxamer gels.
    Shin SC; Cho CW; Choi HK
    Drug Dev Ind Pharm; 1999 Mar; 25(3):273-8. PubMed ID: 10071819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro percutaneous absorption of tenoxicam from pressure-sensitive adhesive matrices across the hairless mouse skin.
    Gwak HS; Chun IK
    Arch Pharm Res; 2001 Dec; 24(6):578-83. PubMed ID: 11794539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nonionic surfactants on the percutaneous absorption tenoxicam.
    Endo M; Yamamoto T; Ijuin T
    Chem Pharm Bull (Tokyo); 1996 Apr; 44(4):865-7. PubMed ID: 8681419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Ultrasound Intensity and Mode on Piroxicam Transport Across Three-Dimensional Skin Equivalent Epiderm™.
    Alarjah MA
    Recent Pat Drug Deliv Formul; 2020; 14(1):75-83. PubMed ID: 32106808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin enhanced transdermal delivery of piroxicam and carboxyfluorescein by electroporation.
    Murthy SN; Zhao YL; Sen A; Hui SW
    J Control Release; 2004 Oct; 99(3):393-402. PubMed ID: 15451597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.